The role of kallikrein-kinin system in type I diabetes (insulitis)

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 349-350

  Zuccollo, Adriana ^a   Cueva, Fernando ^b   Frontera, Miriam ^a   Navarro, Mónica ^a   Catanzaro, Orlando ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Hospital Israelita   (Argentina)

Author keywords

diabetes; kallikrein kinin system

Indexed keywords

APROTININ; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ[8 LEUCINE 9 DEARGININE]; GLUCOSE; ICATIBANT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTRAPERITONEAL DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030176038     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00095-1     Document Type: Conference Paper

References (10)

1. Catanzaro OL, Marina Prendes MG, Hope S, Zuccollo A, Dominguez A, Brazilian J Med Biol Res 1994; 27: 2043-2047.
2. Cooke A, Curr Top Microbiol Immunol 1990; 164: 125-142.
3. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnokj S, Tennenbaum SR. Anal Biochem 1982; 126: 131-138.
4. Leitier EH, Beamer WG, Schultz L. Diabetes 1983; 32: 148-155.
5. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. J Biol Chem 1951; 193: 265-275.
6. Raabo E, Torkildsen T. Scand J Clin 1960; 12: 402-404.
7. Sharma JN, Moshin SSJ. Expl Pathol 1990; 38: 73-96.
8. Sharma JN. Eur J Reumatol Inflamm 1991; 11: 30-36.
9. Tiffany CW, Burch RM. FEBS Lett 1989; 247: 189-192.
10. Vila SB, Peluffo V, Alvarado C, Cresto JC, Zuccollo A, Catanzaro OL. (1992) Recent Progress on Kinins. Bonner et al., Birkhauser, Basel, pp. 304-310.